(Q79239916)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17040833%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

title

Chemotherapy of schistosomiasis: an update (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17040833%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1 reference

1 reference

D Cioli

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17040833%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

publication date

1 October 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17040833%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17040833%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17040833%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17040833%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

page(s)

418-422

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17040833%20AND%20SRC:MED&resulttype=core&format=json

Antischistosomal drugs: past, present ... and future?

20 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901323-4

7 January 2021

Protection against schistosomiasis produced by cyclosporin A

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901323-4

7 January 2021

Cyclophilin of Schistosoma japonicum

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901323-4

7 January 2021

Characterization of a Schistosoma mansoni cDNA encoding a B-like cyclophilin and its expression in Escherichia coli.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901323-4

7 January 2021

Sequence conservation of schistosome cyclophilins.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901323-4

7 January 2021

Expression cloning and biochemical characterizations of recombinant cyclophilin proteins from Schistosoma mansoni

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901323-4

7 January 2021

In vitro and in vivo studies of the effect of artemether on Schistosoma mansoni

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901323-4

7 January 2021

Activity of the artemether in experimental schistosomiasis mansoni

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901323-4

7 January 2021

Antischistosomal activity of acridanone-hydrazones in Cebus monkeys experimentally infected with the SJ strain of Schistosoma mansoni

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901323-4

7 January 2021

Activity of 9-acridanone-hydrazone drugs detected at the pre-postural phase, in the experimental schistosomiasis mansoni

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901323-4

7 January 2021

Schistosomicidal activity of alkylaminooctanethiosulfuric acids.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901323-4

7 January 2021

Metabolism by Schistosoma mansoni of a new schistosomicide: 2-[(1-methylpropyl)amino]-1-octanethiosulphuric acid

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901323-4

7 January 2021

Crystal structures of a schistosomal drug and vaccine target: glutathione S-transferase from Schistosoma japonica and its complex with the leading antischistosomal drug praziquantel

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901323-4

7 January 2021

Schistosoma japonicum GSH S-transferase Sj26 is not the molecular target of praziquantel action

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901323-4

7 January 2021

Praziquantel: The enigmatic antiparasitic

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901323-4

7 January 2021

Praziquantel: an urgent and exciting challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901323-4

7 January 2021

Properties and drug sensitivity of adenosine triphosphatases from Schistosoma mansoni

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901323-4

7 January 2021

Praziquantel has no direct effect on (Na(+)+K+)-ATPases and (Ca2(+)-Mg2+)ATPases of Schistosoma mansoni

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901323-4

7 January 2021

Schistosoma mansoni: Reduced efficacy of chemotherapy in infected T-cell-deprived mice

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901323-4

7 January 2021

Schistosoma mansoni: molecular cloning and sequencing of the 200-kDa chemotherapeutic target antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901323-4

7 January 2021

Effect of praziquantel on protozoan parasites

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901323-4

7 January 2021

High-performance liquid chromatography determination of praziquantel enantiomers in human serum using a reversed-phase cellulose-based chiral stationary phase and disc solid-phase extraction

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901323-4

7 January 2021

Enantioselective analysis of praziquantel in plasma samples

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901323-4

7 January 2021

Efficacy and side effects of praziquantel in an epidemic focus of Schistosoma mansoni.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901323-4

7 January 2021

Therapeutic evaluation of two different dose regimens of praziquantel in a recent Schistosoma mansoni focus in Northern Senegal

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901323-4

7 January 2021

Oxamniquine cures Schistosoma mansoni infection in a focus in which cure rates with praziquantel are unusually low.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901323-4

7 January 2021

Praziquantel, a new broad-spectrum antischistosomal agent

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901323-4

7 January 2021

Schistosoma mansoni: chemotherapy of infections of different ages

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901323-4

7 January 2021

Efficacy of praziquantel against Schistosoma mansoni in northern Senegal

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901323-4

7 January 2021

Characterization of isolates of Schistosoma mansoni from Egyptian villagers that tolerate high doses of praziquantel.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901323-4

7 January 2021

The development of resistance to anthelmintics: a perspective with an emphasis on the antischistosomal drug praziquantel

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901323-4

7 January 2021

Persistence of Schistosoma haematobium infection despite multiple courses of therapy with praziquantel

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901323-4

7 January 2021

Drug-resistant schistosomiasis: resistance to praziquantel and oxamniquine induced in Schistosoma mansoni in mice is drug specific.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901323-4

7 January 2021

Schistosoma mansoni: maturation rate and drug susceptibility of different geographic isolates.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901323-4

7 January 2021

10.1016/S0169-4758(98)01323-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17040833%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1 reference